|
US5614492A
(en)
*
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US5120712A
(en)
*
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US7138486B2
(en)
*
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
|
US6849708B1
(en)
*
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
|
US5118666A
(en)
*
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5527524A
(en)
*
|
1986-08-18 |
1996-06-18 |
The Dow Chemical Company |
Dense star polymer conjugates
|
|
US4857311A
(en)
|
1987-07-31 |
1989-08-15 |
Massachusetts Institute Of Technology |
Polyanhydrides with improved hydrolytic degradation properties
|
|
US5681543A
(en)
*
|
1988-02-29 |
1997-10-28 |
Shering Aktiengesellschaft |
Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
|
|
US5116603A
(en)
*
|
1989-01-31 |
1992-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Oral antifungal preventative, and method of use
|
|
US5554388A
(en)
*
|
1989-02-25 |
1996-09-10 |
Danbiosyst Uk Limited |
Systemic drug delivery compositions comprising a polycationi substance
|
|
US5744166A
(en)
*
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
WO1993009176A2
(en)
*
|
1991-10-29 |
1993-05-13 |
Clover Consolidated, Limited |
Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
|
|
US5770563A
(en)
|
1991-12-06 |
1998-06-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof
|
|
US6113946A
(en)
*
|
1992-04-03 |
2000-09-05 |
The Regents Of The University Of California |
Self-assembling polynucleotide delivery system comprising dendrimer polycations
|
|
AU682308C
(en)
*
|
1992-04-03 |
2006-08-17 |
Regents Of The University Of California, The |
Self-assembling polynucleotide delivery system
|
|
JPH08501097A
(ja)
*
|
1992-09-04 |
1996-02-06 |
ザ ゼネラル ホスピタル コーポレーション |
臨床診断及び治療用部分を含む生体適合性ポリマー
|
|
US5871710A
(en)
*
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
|
US5395619A
(en)
*
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
|
US6284727B1
(en)
*
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
US5681811A
(en)
*
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5605672A
(en)
*
|
1993-06-09 |
1997-02-25 |
The General Hospital Corporation |
Blood pool imaging composition and method of its use
|
|
US5763585A
(en)
*
|
1993-10-13 |
1998-06-09 |
Anergen, Inc. |
Method of making MHC-peptide complexes using metal chelate affinity chromatography
|
|
MX9504664A
(es)
*
|
1994-03-07 |
1997-05-31 |
Dow Chemical Co |
Conjugados de dendrimeros bioactivos y/o dirigidos.
|
|
US5466467A
(en)
|
1994-03-30 |
1995-11-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Liposomes containing polymerized lipids for non-covalent immobilization of proteins and enzymes
|
|
GB9409496D0
(en)
*
|
1994-05-12 |
1994-06-29 |
London Health Ass |
Method for improving glycaemic control in diabetes
|
|
US20010006943A1
(en)
|
1994-12-23 |
2001-07-05 |
Ejvind Jensen |
Protracted GLP-1 compositions
|
|
US5855610A
(en)
|
1995-05-19 |
1999-01-05 |
Children's Medical Center Corporation |
Engineering of strong, pliable tissues
|
|
US5891418A
(en)
*
|
1995-06-07 |
1999-04-06 |
Rhomed Incorporated |
Peptide-metal ion pharmaceutical constructs and applications
|
|
EP0830381A4
(en)
*
|
1995-06-09 |
2000-11-22 |
William N Drohan |
CHITINE HYDROGELS, PRODUCTION METHOD AND USE
|
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
|
AU730969B2
(en)
|
1995-10-19 |
2001-03-22 |
University Of Washington |
Discrete-length polyethylene glycols
|
|
US5683387A
(en)
*
|
1996-01-29 |
1997-11-04 |
Garito; Jon C. |
Electrosurgical electrode for skin grafting
|
|
PL189698B1
(pl)
|
1996-03-12 |
2005-09-30 |
Pg Txl Co |
Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
|
|
US6254854B1
(en)
*
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
US6006753A
(en)
*
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
UA65549C2
(uk)
*
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6153211A
(en)
|
1997-07-18 |
2000-11-28 |
Infimed, Inc. |
Biodegradable macromers for the controlled release of biologically active substances
|
|
US6468532B1
(en)
|
1998-01-22 |
2002-10-22 |
Genentech, Inc. |
Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates
|
|
US6703359B1
(en)
*
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
US6998387B1
(en)
|
1998-03-19 |
2006-02-14 |
Amylin Pharmaceuticals, Inc. |
Human appetite control by glucagon-like peptide receptor binding compounds
|
|
GB9811059D0
(en)
*
|
1998-05-23 |
1998-07-22 |
Univ Strathclyde |
Polyamino acid vesicles
|
|
US6509323B1
(en)
*
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
US7056734B1
(en)
|
1998-08-10 |
2006-06-06 |
The United States Of America As Represented By The Department Of Health And Human Services, Nih |
Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
|
|
IL140892A0
(en)
*
|
1998-08-12 |
2002-02-10 |
Yissum Res Dev Co |
Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
|
|
US6284725B1
(en)
*
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
|
JP2002534363A
(ja)
*
|
1999-01-08 |
2002-10-15 |
エミスフェアー・テクノロジーズ・インク |
ポリマー性デリバリー剤及びデリバリー剤化合物
|
|
US6365173B1
(en)
*
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
|
CA2328614C
(en)
*
|
1999-02-12 |
2012-06-26 |
Biostream, Inc. |
Matrices for drug delivery and methods for making and using the same
|
|
US6569832B1
(en)
|
1999-11-12 |
2003-05-27 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
|
CN1487836A
(zh)
*
|
2000-03-14 |
2004-04-07 |
埃米林药品公司 |
胰高糖素样肽1(7-36)对胃窦幽门十二指肠能动性的影响
|
|
US6998137B2
(en)
*
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
|
US6589549B2
(en)
*
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
AU2001263230B2
(en)
*
|
2000-05-19 |
2005-03-10 |
Amylin Pharmaceuticals, Llc |
Treatment of acute coronary syndrome with glp-1
|
|
US6338859B1
(en)
*
|
2000-06-29 |
2002-01-15 |
Labopharm Inc. |
Polymeric micelle compositions
|
|
DK1301213T3
(en)
|
2000-07-21 |
2017-03-27 |
Revance Therapeutics Inc |
MULTI-COMPONENT SYSTEMS FOR BIOLOGICAL TRANSPORT
|
|
US20040092432A1
(en)
*
|
2000-08-24 |
2004-05-13 |
Thomas Jefferson University |
Peptide compositions with effects on cerebral health
|
|
US6521736B2
(en)
|
2000-09-15 |
2003-02-18 |
University Of Massachusetts |
Amphiphilic polymeric materials
|
|
CA2395165C
(en)
*
|
2000-10-20 |
2012-05-22 |
Mario Ehlers |
Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide
|
|
AU2002239384B2
(en)
*
|
2000-12-13 |
2007-01-11 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
AU2002228608A1
(en)
*
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
|
JP4775985B2
(ja)
*
|
2000-12-27 |
2011-09-21 |
三井化学株式会社 |
重合体及びその製造方法
|
|
ES2315350T3
(es)
|
2001-01-12 |
2009-04-01 |
Waratah Pharmaceuticals Inc. |
Composiciones para la introduccion de la neogenesis de islotes, que contienen unos ligandos para el receptor de gastrina/cck y ligandos para el receptor de efg.
|
|
JP2005506956A
(ja)
*
|
2001-06-01 |
2005-03-10 |
イーライ・リリー・アンド・カンパニー |
長時間作用性ｇｌｐ−１製剤
|
|
ES2298378T3
(es)
|
2001-06-28 |
2008-05-16 |
Novo Nordisk A/S |
Formulacion estable de glp-1 modificado.
|
|
US6586524B2
(en)
*
|
2001-07-19 |
2003-07-01 |
Expression Genetics, Inc. |
Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
|
|
AU2002322403A1
(en)
*
|
2001-08-23 |
2003-03-10 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
|
HUP0600437A2
(en)
|
2001-10-01 |
2006-09-28 |
Lilly Co Eli |
Glucagon-like peptides (glp-1) and treatment of respiratory distress
|
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
|
IL161446A0
(en)
|
2001-11-26 |
2004-09-27 |
Daiichi Suntory Pharma Co Ltd |
Medicinal compositions for nasal absorption
|
|
AU2003208945B2
(en)
|
2002-02-20 |
2008-05-01 |
Emisphere Technologies, Inc |
Method for administering GLP-1 molecules
|
|
US20050260259A1
(en)
*
|
2004-04-23 |
2005-11-24 |
Bolotin Elijah M |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
AU2003219922B2
(en)
*
|
2002-02-27 |
2009-09-10 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
|
MXPA04012497A
(es)
|
2002-07-04 |
2005-07-14 |
Zealand Pharma As |
Glp-1 y metodos para tratar la diabetes.
|
|
US20040086569A1
(en)
*
|
2002-08-13 |
2004-05-06 |
Medtronic, Inc. |
Active agent delivery systems, medical devices, and methods
|
|
CA2497794A1
(en)
|
2002-09-06 |
2004-03-18 |
Bayer Pharmaceuticals Corporation |
Modified glp-1 receptor agonists and their pharmacological methods of use
|
|
GB0221941D0
(en)
|
2002-09-20 |
2002-10-30 |
Univ Strathclyde |
Polysoaps
|
|
US7648962B2
(en)
*
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
|
US20040209803A1
(en)
|
2002-12-19 |
2004-10-21 |
Alain Baron |
Compositions for the treatment and prevention of nephropathy
|
|
US7790681B2
(en)
|
2002-12-17 |
2010-09-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of cardiac arrhythmias with GLP-1 receptor ligands
|
|
RU2005133427A
(ru)
|
2003-03-31 |
2006-04-27 |
Алза Корпорейшн (Us) |
Безводные однофазные носители и препараты с использованием таких носителей
|
|
US8008255B2
(en)
|
2003-05-30 |
2011-08-30 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
KR101308912B1
(ko)
|
2003-06-03 |
2013-09-23 |
노보 노르디스크 에이/에스 |
안정화된 약학적 펩티드 조성물
|
|
ES2375056T3
(es)
|
2003-06-03 |
2012-02-24 |
Novo Nordisk A/S |
Composiciones pept�?dicas farmacéuticas estabilizadas.
|
|
US20060247167A1
(en)
|
2003-09-01 |
2006-11-02 |
Novo Nordisk A/S |
Stable formulations of peptides
|
|
JP2007514752A
(ja)
|
2003-12-16 |
2007-06-07 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
Ｇｌｐ−１医薬組成物
|
|
WO2005084180A2
(en)
|
2003-12-19 |
2005-09-15 |
University Of Cincinnati |
Polyamides and polyamide complexes for delivery of oligonucleotide decoys
|
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
|
US20050143303A1
(en)
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
|
BRPI0508440A
(pt)
|
2004-03-03 |
2007-07-24 |
Revance Therapeutics Inc |
composições e métodos para diagnóstico tópico e transporte terapêutico
|
|
FR2867679B1
(fr)
|
2004-03-17 |
2008-08-22 |
Oreal |
Composition cosmetiques comprenant des polyamines modifiees et utilisations desdites compositions.
|
|
US7985424B2
(en)
|
2004-04-20 |
2011-07-26 |
Dendritic Nanotechnologies Inc. |
Dendritic polymers with enhanced amplification and interior functionality
|
|
EP1737899B1
(en)
|
2004-04-20 |
2015-07-08 |
Dendritic Nanotechnologies, Inc. |
Dendritic polymers with enhanced amplification and interior functionality
|
|
US20060134166A1
(en)
|
2004-05-25 |
2006-06-22 |
Luthra Ajay K |
Absorbable biocompatible materials
|
|
WO2006080951A2
(en)
*
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
US9089636B2
(en)
|
2004-07-02 |
2015-07-28 |
Valeritas, Inc. |
Methods and devices for delivering GLP-1 and uses thereof
|
|
CN101027318B
(zh)
|
2004-07-19 |
2016-05-25 |
比奥孔有限公司 |
胰岛素-低聚物共轭物，制剂及其用途
|
|
US20060233857A1
(en)
*
|
2005-04-14 |
2006-10-19 |
Amsden Brian G |
Degradable elastomeric network
|
|
US20090202497A1
(en)
|
2005-08-23 |
2009-08-13 |
The General Hospital Corporation |
Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
|
|
WO2007030706A1
(en)
|
2005-09-08 |
2007-03-15 |
New England Medical Center Hospitals, Inc. |
Fragments of the glucagon-like peptide-i and uses thereof
|
|
AU2005337069B2
(en)
|
2005-10-05 |
2011-08-11 |
Essity Hygiene And Health Aktiebolag |
Absorbent article comprising hydrophilic and hydrophobic regions
|
|
HUE031341T2
(hu)
|
2005-10-25 |
2017-07-28 |
Starpharma Pty Ltd |
Ellenõrzött sztöchiometriájú makromolekuláris vegyületek
|
|
PL1965823T3
(pl)
|
2005-11-04 |
2017-08-31 |
Glaxosmithkline Llc |
Sposoby podawania środków hipoglikemicznych
|
|
KR101529318B1
(ko)
|
2005-12-19 |
2015-06-16 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법
|
|
WO2007082331A1
(en)
|
2006-01-20 |
2007-07-26 |
Starpharma Pty Limited |
Modified macromolecule
|
|
US7960336B2
(en)
*
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US20090176892A1
(en)
*
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|